share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  09/24 17:02

Moomoo AI 已提取核心信息

On September 24, 2024, Aclarion, Inc. announced the entry into an At-the-Market Issuance Sales Agreement with Ascendiant Capital Markets, LLC to sell shares of its common stock with an aggregate offering price of up to $10 million. The sales will be conducted through an at-the-market offering, subject to the limitations of General Instruction I.B.6 of Form S-3. A prospectus supplement was filed with the SEC for the sale of up to $1,075,000 of common stock under this offering. The shares will be sold pursuant to Aclarion's effective shelf registration statement, which was filed on September 9, 2024, and declared effective by the SEC on September 23, 2024. The Agent will sell the shares based on the company's instructions and within legal and regulatory guidelines. Aclarion will pay a commission of up to 3.0% of the gross proceeds from the sales and reimburse the Agent for certain expenses. Both Aclarion and the Agent have the right to terminate the Sales Agreement at their discretion.
On September 24, 2024, Aclarion, Inc. announced the entry into an At-the-Market Issuance Sales Agreement with Ascendiant Capital Markets, LLC to sell shares of its common stock with an aggregate offering price of up to $10 million. The sales will be conducted through an at-the-market offering, subject to the limitations of General Instruction I.B.6 of Form S-3. A prospectus supplement was filed with the SEC for the sale of up to $1,075,000 of common stock under this offering. The shares will be sold pursuant to Aclarion's effective shelf registration statement, which was filed on September 9, 2024, and declared effective by the SEC on September 23, 2024. The Agent will sell the shares based on the company's instructions and within legal and regulatory guidelines. Aclarion will pay a commission of up to 3.0% of the gross proceeds from the sales and reimburse the Agent for certain expenses. Both Aclarion and the Agent have the right to terminate the Sales Agreement at their discretion.
Aclarion公司于2024年9月24日宣布与Ascendiant资本市场公司签订了一项根据表格S-3第I.b.6条款限制范围内的以市场为基础的发行销售协议,出售其普通股,总发行价高达1000万美元。根据此次发行,已向SEC提交了一份招股说明书,用于出售高达1,075,000美元的普通股。这些股票将根据Aclarion有效的上市注册声明出售,该声明于2024年9月9日提交,并于2024年9月23日被SEC宣告生效。代理将根据公司的指示和法律法规的规定出售股票。Aclarion将支付销售收入的最高3.0%作为佣金,并补偿代理的某些费用。Aclarion和代理都有权根据自己的意愿终止销售协议。
Aclarion公司于2024年9月24日宣布与Ascendiant资本市场公司签订了一项根据表格S-3第I.b.6条款限制范围内的以市场为基础的发行销售协议,出售其普通股,总发行价高达1000万美元。根据此次发行,已向SEC提交了一份招股说明书,用于出售高达1,075,000美元的普通股。这些股票将根据Aclarion有效的上市注册声明出售,该声明于2024年9月9日提交,并于2024年9月23日被SEC宣告生效。代理将根据公司的指示和法律法规的规定出售股票。Aclarion将支付销售收入的最高3.0%作为佣金,并补偿代理的某些费用。Aclarion和代理都有权根据自己的意愿终止销售协议。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息